ステロイド注射市場：製品タイプ、投与経路、流通チャネル、用途別-2025-2030年の世界予測

ステロイド注射市場は、2023年に38億米ドルと評価され、2024年には42億9,000万米ドルに達すると予測され、CAGR 13.54％で成長し、2030年には92億5,000万米ドルに達すると予測されています。

ステロイド注射は、炎症や痛みを抑えるために、副腎皮質ステロイドを体内の炎症や痛みのある部位に直接投与する治療法です。関節炎、腱炎、滑液包炎などの症状に不可欠であり、これらの注射は大きな緩和をもたらし、可動性を改善するため、他の治療に反応しない患者に必要です。ステロイド注射は、病院の外来、クリニック、個人医院など様々な医療現場で使用されており、エンドユーザーは整形外科専門医からスポーツ医まで多岐にわたります。ステロイド注射市場は、筋骨格系障害の有病率の増加、高齢者人口の増加、低侵襲処置の需要の高まりによって成長を遂げています。ドラッグデリバリーシステムの技術的進歩と新規コルチコステロイドの開発は、市場プレーヤーに有利な機会を提供します。戦略的パートナーシップや研究開発投資を通じてこれらに対処すれば、市場での存在感を高めることができます。しかし、副作用の可能性、厳しい規制要件、身体リハビリテーションや経口薬などの代替療法の利用可能性といった制約があり、これが市場の成長を妨げる可能性があります。技術革新を推進するため、企業は患者の予後を改善する注射薬の製剤改良に注力し、副作用を最小限に抑える次世代デリバリー技術を探求すべきです。新興国市場は、ヘルスケアのインフラが整備され、先進的な治療ソリューションに対する認識が高まっているため、潜在的な成長が期待でき、これらの地域への投資は戦略的であろう。課題にもかかわらず、ステロイド注射市場の性質は、効果的な疼痛管理と炎症制御療法に対する継続的な需要に支えられ、堅調なままです。技術革新と並んで、患者のニーズとヘルスケア動向を包括的に理解することは、この競合市場の情勢において、拡大と適応のための大きな機会を提供することができます。

市場力学：急速に進化するステロイド注射市場の主要市場インサイトを公開

ステロイド注射市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 整形外科疾患の発生に伴う老人人口の増加
  • 若年層におけるボディービル人気の高まり
• 市場抑制要因
  • ステロイド注射の使用に対する厳しい規制
• 市場機会
  • 整形外科手術への魅力の高まり
  • ステロイド注射のイントロダクションと承認
• 市場の課題
  • ステロイド消費に伴う有害な副作用

ポーターの5つの力：ステロイド注射市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ステロイド注射市場における外部からの影響の把握

外部マクロ環境要因は、ステロイド注射市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ステロイド注射市場における競合情勢の把握

ステロイド注射市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスステロイド注射市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ステロイド注射市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ステロイド注射市場における成功への道筋を描く

ステロイド注射市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢者人口の増加と整形外科疾患の発生
    • 若者の間でボディービルが人気
  • 抑制要因
    • ステロイド注射の使用に関する厳格な規制
  • 機会
    • 美容整形への関心の高まり
    • ステロイド注射のイントロダクションと承認
  • 課題
    • ステロイドの摂取に伴う有害な副作用
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ステロイド注射市場：製品タイプ別

• コルチゾン
• ヒドロコルチゾン
• メチルプレドニゾロン
• トリアムシノロン

第7章 ステロイド注射市場投与経路別

• 硬膜外麻酔
• 関節内
• 筋肉内
• 静脈内

第8章 ステロイド注射市場：流通チャネル別

• 病院薬局
• 小売薬局
• 専門クリニック

第9章 ステロイド注射市場：用途別

• 強直性脊椎炎
• 腰痛
• 滑液包炎
• がん
• 痛風
• 変形性関節症
• 乾癬性関節炎
• 関節リウマチ

第10章 南北アメリカのステロイド注射市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のステロイド注射市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのステロイド注射市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Actiza Pharmaceutical Private Limited
• AdvaCare Pharma
• ANI Pharmaceuticals, Inc.,
• Bristol-Myers Squibb Company
• Farmabios GmbH
• Flagship Biotech International Private Limited.
• Flexion Therapeutics Inc.
• GSK plc
• Health Biotech Limited
• Intrapharm Laboratories
• Merck & Co., Inc.
• Merit Healthcare International Inc.
• Mylan N.V.
• Novartis AG
• Perrigo Company plc

LIST OF FIGURES

• FIGURE 1. STEROID INJECTIONS MARKET RESEARCH PROCESS
• FIGURE 2. STEROID INJECTIONS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL STEROID INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL STEROID INJECTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. STEROID INJECTIONS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. STEROID INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. STEROID INJECTIONS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL STEROID INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL STEROID INJECTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. STEROID INJECTIONS MARKET DYNAMICS
• TABLE 7. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL STEROID INJECTIONS MARKET SIZE, BY CORTISONE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HYDROCORTISONE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL STEROID INJECTIONS MARKET SIZE, BY METHYLPREDNISOLONE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TRIAMCINOLONE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL STEROID INJECTIONS MARKET SIZE, BY EPIDURAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL STEROID INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL STEROID INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL STEROID INJECTIONS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ANKYLOSING SPONDYLITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BURSITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL STEROID INJECTIONS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL STEROID INJECTIONS MARKET SIZE, BY GOUT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL STEROID INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PSORIATIC ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL STEROID INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. CANADA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 44. CANADA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 45. CANADA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 46. CANADA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 62. AUSTRALIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. CHINA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 66. CHINA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 67. CHINA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 68. CHINA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. INDIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 70. INDIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 71. INDIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 72. INDIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. INDONESIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 74. INDONESIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 75. INDONESIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 76. INDONESIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. JAPAN STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 78. JAPAN STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 79. JAPAN STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 80. JAPAN STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. MALAYSIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 82. MALAYSIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 83. MALAYSIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 84. MALAYSIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. PHILIPPINES STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 86. PHILIPPINES STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 87. PHILIPPINES STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 88. PHILIPPINES STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SINGAPORE STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SINGAPORE STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 91. SINGAPORE STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 92. SINGAPORE STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. SOUTH KOREA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 94. SOUTH KOREA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 95. SOUTH KOREA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 96. SOUTH KOREA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. TAIWAN STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 98. TAIWAN STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 99. TAIWAN STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 100. TAIWAN STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. THAILAND STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 102. THAILAND STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 103. THAILAND STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 104. THAILAND STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. VIETNAM STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 106. VIETNAM STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 107. VIETNAM STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 108. VIETNAM STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 111. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 112. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 114. DENMARK STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 115. DENMARK STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 116. DENMARK STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 117. DENMARK STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. EGYPT STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 119. EGYPT STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 120. EGYPT STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 121. EGYPT STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. FINLAND STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 123. FINLAND STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 124. FINLAND STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 125. FINLAND STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. FRANCE STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 127. FRANCE STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 128. FRANCE STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 129. FRANCE STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. GERMANY STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 131. GERMANY STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 132. GERMANY STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 133. GERMANY STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. ISRAEL STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 135. ISRAEL STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 136. ISRAEL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 137. ISRAEL STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. ITALY STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 139. ITALY STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 140. ITALY STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 141. ITALY STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 143. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 144. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 145. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. NIGERIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 147. NIGERIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 148. NIGERIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 149. NIGERIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. NORWAY STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 151. NORWAY STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 152. NORWAY STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 153. NORWAY STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. POLAND STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 155. POLAND STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 156. POLAND STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 157. POLAND STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. QATAR STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 159. QATAR STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 160. QATAR STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 161. QATAR STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. RUSSIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 163. RUSSIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 164. RUSSIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 165. RUSSIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 167. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 168. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 169. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 171. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 172. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 173. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. SPAIN STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 175. SPAIN STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 176. SPAIN STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 177. SPAIN STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. SWEDEN STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 179. SWEDEN STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 180. SWEDEN STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 181. SWEDEN STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. SWITZERLAND STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 183. SWITZERLAND STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 184. SWITZERLAND STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 185. SWITZERLAND STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. TURKEY STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 187. TURKEY STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 188. TURKEY STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 189. TURKEY STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 191. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 192. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 193. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 194. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 195. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 196. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 197. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 198. STEROID INJECTIONS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 199. STEROID INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2023

The Steroid Injections Market was valued at USD 3.80 billion in 2023, expected to reach USD 4.29 billion in 2024, and is projected to grow at a CAGR of 13.54%, to USD 9.25 billion by 2030.

Steroid injections are a medical treatment involving the administration of corticosteroids directly into inflamed or painful areas in the body to reduce inflammation and pain. Essential for conditions like arthritis, tendonitis, and bursitis, these injections provide significant relief and improve mobility, making them necessary for patients unresponsive to other treatments. Steroid injections are applied in various medical settings, including hospital outpatient departments, clinics, and private medical practices, with end-users ranging from orthopedic specialists to sports medicine practitioners. The market for steroid injections is witnessing growth driven by the increasing prevalence of musculoskeletal disorders, the rising geriatric population, and growing demand for minimally invasive procedures. Technological advancements in drug delivery systems and the development of novel corticosteroids present lucrative opportunities for market players. Addressing these through strategic partnerships and R&D investments can enhance market presence. However, the market faces limitations such as the potential for side effects, stringent regulatory requirements, and the availability of alternative therapies like physical rehabilitation and oral medications, which can hinder growth. To drive innovation, companies should focus on improving the formulation of injectable drugs for better patient outcomes and explore next-generation delivery technologies that minimize adverse effects. Markets in emerging economies offer potential growth due to increasing healthcare infrastructure and rising awareness of advanced therapeutic solutions, suggesting investment in these regions would be strategic. Despite challenges, the nature of the steroid injection market remains robust, sustained by continuous demand for effective pain management and inflammation control therapies. A comprehensive understanding of patient needs and healthcare trends, alongside technological innovation, can offer substantial opportunities for expansion and adaptation in this competitive market landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Steroid Injections Market

The Steroid Injections Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing geriatric population along with occurrences of orthopedic disorders
  • Popularity of bodybuilding among young people
• Market Restraints
  • Stringent regulation for steroid injection usage
• Market Opportunities
  • Growing attraction towards plastic surgeries
  • Introduction and approval of the steroid injections
• Market Challenges
  • Harmful side effects associated with the consumption of steroids

Porter's Five Forces: A Strategic Tool for Navigating the Steroid Injections Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Steroid Injections Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Steroid Injections Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Steroid Injections Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Steroid Injections Market

A detailed market share analysis in the Steroid Injections Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Steroid Injections Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Steroid Injections Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Steroid Injections Market

A strategic analysis of the Steroid Injections Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Steroid Injections Market, highlighting leading vendors and their innovative profiles. These include Actiza Pharmaceutical Private Limited, AdvaCare Pharma, ANI Pharmaceuticals, Inc.,, Bristol-Myers Squibb Company, Farmabios GmbH, Flagship Biotech International Private Limited., Flexion Therapeutics Inc., GSK plc, Health Biotech Limited, Intrapharm Laboratories, Merck & Co., Inc., Merit Healthcare International Inc., Mylan N.V., Novartis AG, and Perrigo Company plc.

Market Segmentation & Coverage

This research report categorizes the Steroid Injections Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Cortisone, Hydrocortisone, Methylprednisolone, and Triamcinolone.
• Based on Administration Route, market is studied across Epidural, Intra-Articular, Intramuscular, and Intravenous.
• Based on Distribution Channel, market is studied across Hospital Pharmacy, Retail Pharmacy, and Specialty Clinics.
• Based on Application, market is studied across Ankylosing Spondylitis, Back pain, Bursitis, Cancer, Gout, Osteoarthritis, Psoriatic Arthritis, and Rheumatoid Arthritis.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing geriatric population along with occurrences of orthopedic disorders
    • 5.1.1.2. Popularity of bodybuilding among young people
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent regulation for steroid injection usage
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing attraction towards plastic surgeries
    • 5.1.3.2. Introduction and approval of the steroid injections
  • 5.1.4. Challenges
    • 5.1.4.1. Harmful side effects associated with the consumption of steroids
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Steroid Injections Market, by Product Type

• 6.1. Introduction
• 6.2. Cortisone
• 6.3. Hydrocortisone
• 6.4. Methylprednisolone
• 6.5. Triamcinolone

7. Steroid Injections Market, by Administration Route

• 7.1. Introduction
• 7.2. Epidural
• 7.3. Intra-Articular
• 7.4. Intramuscular
• 7.5. Intravenous

8. Steroid Injections Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Hospital Pharmacy
• 8.3. Retail Pharmacy
• 8.4. Specialty Clinics

9. Steroid Injections Market, by Application

• 9.1. Introduction
• 9.2. Ankylosing Spondylitis
• 9.3. Back pain
• 9.4. Bursitis
• 9.5. Cancer
• 9.6. Gout
• 9.7. Osteoarthritis
• 9.8. Psoriatic Arthritis
• 9.9. Rheumatoid Arthritis

10. Americas Steroid Injections Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Steroid Injections Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Steroid Injections Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Actiza Pharmaceutical Private Limited
• 2. AdvaCare Pharma
• 3. ANI Pharmaceuticals, Inc.,
• 4. Bristol-Myers Squibb Company
• 5. Farmabios GmbH
• 6. Flagship Biotech International Private Limited.
• 7. Flexion Therapeutics Inc.
• 8. GSK plc
• 9. Health Biotech Limited
• 10. Intrapharm Laboratories
• 11. Merck & Co., Inc.
• 12. Merit Healthcare International Inc.
• 13. Mylan N.V.
• 14. Novartis AG
• 15. Perrigo Company plc